The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
exposure to both ATR and DACT has adverse impact on dopaminergic cells, including<br />
a disruption <strong>of</strong> the normal differentiation process. Moreover, it appears that<br />
ATR and DACT affect the dopaminergic cell differentiation process differently.<br />
1358 EFFECT OF HEXACHLOROBENZENE(HCB)ON THE<br />
NEURONAL DIFFERENTIATION OF MOUSE<br />
EMBRYONIC STEM CELLS.<br />
C. Addae and E. Martinez-Ceballos. Environmental <strong>Toxicology</strong>, Southern University<br />
and A&M College, Baton Rouge, LA. Sponsor: R. Uppu.<br />
Embryonic stem (ES) cells are pluripotent cells that can differentiate into all three<br />
main germ layers: endoderm, mesoderm, and ectoderm. A number <strong>of</strong> methods<br />
have been developed to differentiate ES cells into specific cell types in culture. In<br />
preliminary studies, we have found that encapsulation <strong>of</strong> ES cells in alginate-based<br />
hydrogels increases the efficiency <strong>of</strong> ES cell neuronal differentiation. Now we have<br />
made use <strong>of</strong> this model system to examine the effect that environmental pollutants<br />
have on ES differentiation. One <strong>of</strong> such pollutants, hexachlorobenzene (HCB), is a<br />
synthetic industrial chemical that is bioaccumulative, persistent, and a toxic pollutant<br />
in the environment. Exposure to this substance is a public health concern because<br />
<strong>of</strong> its association with a wide range <strong>of</strong> adverse health effects. It is believed that<br />
HCB can interfere with brain development and cause mental disorders such as<br />
autism. Thus the goal <strong>of</strong> this research is to investigate the effect <strong>of</strong> HCB on neuronal<br />
differentiation <strong>of</strong> mouse ES cells. To achieve this goal, ES cells were grown in<br />
suspension in ES medium and treated with 10nM HCB for 24, 48, and 72 hours.<br />
Fresh medium was added at the end <strong>of</strong> the treatments and the resulting embryoid<br />
bodies (EBs) were harvested on day 8 <strong>of</strong> culture. Immun<strong>of</strong>luorescence analysis was<br />
performed to examine the effect <strong>of</strong> HCB on neuronal differentiation. Results<br />
showed that HCB has an inhibitory effect on the neuronal differentiation <strong>of</strong> the<br />
mouse ES cells. Because cell death was prominent in HCB-treated ES cells as compared<br />
to controls, the dose-dependent effect <strong>of</strong> HCB on ES neuronal differentiation<br />
was also examined. Our studies suggest that low doses <strong>of</strong> persistent pollutants<br />
may affect the differentiating capabilities <strong>of</strong> ES cells. <strong>The</strong> relationship <strong>of</strong> our findings<br />
to neurological disorders such as autism is discussed in this work.<br />
1359 INCREASED FREQUENCIES OF MICRONUCLEATED<br />
RETICULOCYTES RELATED TO ALDH2<br />
POLYMORPHISMS IN NON-SMOKING AND NON-<br />
DRINKING WORKERS EXPOSED TO STYRENE.<br />
Z. Weng 1 , D. Guan 2 , X. Zhang 4 , P. Zhao 3 , Y. Zheng 4 and R. Wang 1 . 1 Japan<br />
National Institute <strong>of</strong> Occupational Safety and Health, Kawasaki, Japan, 2 Beijing<br />
Fengtai Health Inspection Institute, Beijing, China, 3 Beijing Guoji Zhongyi Hospital,<br />
Beijing, China and 4 National Institute <strong>of</strong> Occupational Health and Poison Control,<br />
China, Beijing, China. Sponsor: N. Mei.<br />
To determine the effect <strong>of</strong> occupational exposure to styrene on frequencies <strong>of</strong> micronucleated<br />
reticulocytes (MN-RETs), we recruited 115 reinforced plastic workers<br />
and 90 unexposed healthy individuals (both exposure group and control group<br />
were non-smoking and non-drinking). In addition, considering genetic polymorphisms<br />
can have an effect on styrene-induced toxicity, we evaluated the associations<br />
between aldehyde dehydrogenase 2 (ALDH2) polymorphisms and styrene-induced<br />
frequencies <strong>of</strong> MN-RETs. Results showed that frequencies <strong>of</strong> MN-RETs were significantly<br />
increased in styrene-exposed workers than unexposed individuals. In<br />
styrene-exposed workers, variant allele ALDH2 *2 was significantly associated with<br />
increased frequencies <strong>of</strong> MN-RETs. However, no effect was observed <strong>of</strong> ALDH2<br />
polymorphisms on frequencies <strong>of</strong> MN-RETs in unexposed individuals. Our data<br />
indicated that styrene exposure seems to be associated with genotoxicity, and this<br />
toxicity may be modulated by ALDH2 polymorphisms.<br />
1360 MODULATION OF DNA REPAIR CAPACITY BY XPC<br />
HAPLOTYPES.<br />
C. M. Rondelli 1 , J. K. Wickliffe 2 and S. Z. Abdel-Rahman 1 . 1 NCB & ObGyn,<br />
University <strong>of</strong> Texas Medical Branch, Galveston, TX and 2 Environmental Health<br />
Sciences, Tulane University, New Orleans, LA.<br />
Xeroderma pigmentosum complementation group C protein, encoded by the XPC<br />
gene, plays a key role in DNA nucleotide excision repair (NER). XPC is highly<br />
polymorphic, with over 90 single nucleotide polymorphisms (SNPs). <strong>The</strong>se SNPs<br />
could alter the levels, structure and function <strong>of</strong> the encoded XPC protein, thus altering<br />
DNA repair capacity (DRC). A comprehensive evaluation <strong>of</strong> all common<br />
XPC SNPs on DNA damage-response and DRC has not been performed. We constructed<br />
a haplotype map encompassing all XPC SNPs with a minor allele fre-<br />
quency ≥0.05, and identified 21 haplotypes that segregated into 6 phylogenetic<br />
groups (PGHs A-F). We evaluated the relationship between these groups <strong>of</strong> haplotypes<br />
and DNA damage associated with smoking, using chromosome aberrations<br />
(CA) as a biomarker. We found a significant interaction between one group, PGH-<br />
C, and smoking for baseline CA (P=0.046). Using mutagen-sensitivity as an intermediate<br />
biomarker <strong>of</strong> cancer risk, we observed significant interactions between<br />
smoking and two groups, PGH-D (P=0.023) and -F (P=0.007). To provide mechanistic<br />
explanations to our findings, we exposed human lymphoblastoid cells with<br />
different XPC haplotypes to UV radiation, to generate cyclobutane pyrimidine<br />
dimers (CPD) and 6-4 photoproducts (6-4PP). Using ELISA, we evaluated the effect<br />
<strong>of</strong> different XPC haplotypes on the repair <strong>of</strong> CPD and 6-4PP. We hypothesized<br />
that if certain XPC haplotypes have functional effects, there would be a correlation<br />
between these haplotypes and rate <strong>of</strong> repair <strong>of</strong> UV-induced genetic damage. Our<br />
preliminary results suggest a preference for the repair <strong>of</strong> 6-4PP over CPD, and show<br />
a significant difference in DRC between different XPC haplotypes. <strong>The</strong> data provides<br />
initial mechanistic explanations <strong>of</strong> the effects <strong>of</strong> XPC haplotypes observed earlier<br />
in smokers and support the reported associations between XPC SNPs and cancer<br />
risk.<br />
1361 DRUG METABOLIZING ENZYME POLYMORPHISMS,<br />
RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN<br />
LUNG CANCER PATIENTS.<br />
A. O. Ada 1 , S. C. Kunak 2 , F. Hancer 1 , S. Bilgen 1 , T. G. Ada 1 , V. Karacaoglan 1 ,<br />
S. Suzen 1 , S. Alpar 3 , M. Gulhan 3 , B. Kurt 3 and M. Iscan 1 . 1 <strong>Toxicology</strong>, Ankara<br />
University, Faculty <strong>of</strong> Pharmacy, Ankara, Turkey, 2 Pharmacology, Giresun University,<br />
Medical Faculty, Giresun, Turkey and 3 Pulmonary Diseases Clinic, Ataturk<br />
Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey.<br />
Lung cancer is an increasing worldwide public health problem particularly in men.<br />
In recent years, several polymorphisms in cytochrome P-450s (CYP)s and glutathione<br />
S-transferases (GST)s have been reported to be associated with survival<br />
rates <strong>of</strong> patients with non-small cell lung cancer (NSCLC) but the studies in this regard<br />
are scarce and the results are contradictory. Moreover, almost no information<br />
is available with respect to the relationship between these polymorphisms and response<br />
to chemotherapy in NSCLC patients. In this study, CYP1A1, CYP1B1,<br />
CYP2E1*5B, GSTM1, GSTO1, GSTP1 exon 5, GSTP1 exon 6 and GSTT1 polymorphisms<br />
were determined in 138 NSCLC patients to evaluate their role in survival<br />
and response to first-line platinum based chemotherapy. <strong>The</strong> polymorphisms<br />
did not significantly influence the responses to platinum based chemotherapy. Of<br />
the studied polymorphisms only GSTP1 exon 6 variant significantly altered (improved)<br />
the survival compared to wild type (p=0.036) with median survival <strong>of</strong> 22.2<br />
months and 16.1 months, respectively. Multivariate analysis also revealed a significant<br />
altered (reduced) adjusted hazard ratio <strong>of</strong> death associated only with the<br />
GSTP1 exon 6 variant genotype <strong>of</strong> 0.45 (95% confidence interval (95% CI), 0.23-<br />
0.89, p=0.022). <strong>The</strong>se results show that a) the studied CYP and GST polymorphisms<br />
are not functioning as a predictor <strong>of</strong> response to first-line platinum based<br />
chemotherapy, and b) the GSTP1 exon 6 variant genotype is associated with improved<br />
survival in the patients with advanced NSCLC. (Supported by the grants<br />
from Research Fund <strong>of</strong> Ankara University Nos: 2006-08-03-002 HPD, 2007-08-<br />
03-005 HPD, 2008-08-03-006 HPD and 10A3336002)<br />
1362 CYP AND GST GENE POLYMORPHISMS IN A TURKISH<br />
POPULATION.<br />
M. Iscan 1 , V. Karacaoglan 1 , S. H. Kunak 2 , E. Soydas 1 , T. G. Ada 1 and A. O.<br />
Ada 1 . 1 Department <strong>of</strong> <strong>Toxicology</strong>, Ankara University, Faculty <strong>of</strong> Pharmacy, Ankara,<br />
Turkey and 2 Department <strong>of</strong> Pharmacology, Giresun University, Faculty <strong>of</strong> Medicine,<br />
Giresun, Turkey.<br />
It is well known that cytochrome P-450 (CYP) enzymes are able to metabolize<br />
many xenobiotics including drugs, polycyclic aromatic hydrocarbons and aromatic<br />
amines to reactive metabolites which could be very toxic and/or carcinogenic. <strong>The</strong><br />
glutathione S-transferases (GST)s are a family <strong>of</strong> cytosolic enzymes generally involved<br />
in the inactivation <strong>of</strong> drugs and toxic, electrophilic, xenobiotics. Thus, genetic<br />
polymorphisms <strong>of</strong> these enzymes can have great impact on the interindividual<br />
susceptibility to toxicities <strong>of</strong> xenobiotics. In this study, CYP2E1, GSTM1, GSTO1,<br />
GSTP1 and GSTT1 gene polymorphisms were determined in 302 healthy individuals.<br />
On the basis <strong>of</strong> an improved polymerase chain reaction/restriction fragment<br />
length polymorphism (PCR/RFLP) methodology, the frequency <strong>of</strong> CYP2E1*5B<br />
(RsaI), GSTO1 (Ala140Asp), GSTP1 codon 105 and GSTP1 codon 114 polymorphisms<br />
were determined. <strong>The</strong> frequencies <strong>of</strong> c1/c1 (wild type), c1/c2 (heterozygous<br />
variant) and c2/c2 (homozygous variant) CYP2E1 genotypes were 94.7 %, 5.3 %<br />
and 0 %, respectively. <strong>The</strong> GSTO1 genotype frequencies were Ala140/Ala140 48.6<br />
SOT 2011 ANNUAL MEETING 291